Yaël P. Mossé - Concepedia

Author

Yaël P. Mossé

Children's Hospital of Philadelphia ORCID

Also Known As

Kennedy, Anne, Mosse, Yael, Mossé, Y., Thompson, Patrick A., Y P Mosse, Y P Mossé, Y. Mosse, Y. Mossé, Y. P. Mosse, Yael (P.) Mossé

328

Publications

12.9K

Citations

H-Index

Concepts

All Affiliations

Children's Hospital of Philadelphia University of Pennsylvania Cancer Research Institute Children's Oncology Group Children's Hospital of Los Angeles

About

Yaël P. Mossé is an author at Children's Hospital of Philadelphia specializing in medicine, pathology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	28	5.2K
2	Public Health	3	3	263
3	Health Sciences	2	2	174
4	Engineering	1	1	12
5	Biostatistics	1	1	82

Yaël P. Mossé

Publications

11K

Citations

H-Index

Page 1

	Year	Citations
Identification of ALK as a major familial neuroblastoma predisposition gene Yaël P. Mossé, Marci Laudenslager, Luca Longo, Nature Genetic DisorderGeneticsPathologyNeuroblastsNeuropathology	2008	1.4K
The genetic landscape of high-risk neuroblastoma Trevor J. Pugh, Olena Morozova, Edward F. Attiyeh, Nature Genetics	2013	1.2K
Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study Yaël P. Mossé, Megan S. Lim, Stephan D. Voss, The Lancet Oncology Refractory Solid TumoursLymphoid NeoplasiaMedicinePediatricsPathology	2013	686
Chromosome 1p and 11q Deletions and Outcome in Neuroblastoma Edward F. Attiyeh, Wendy B. London, Yaël P. Mossé, New England Journal of Medicine	2005	570
Targeting ALK With Crizotinib in Pediatric Anaplastic Large Cell Lymphoma and Inflammatory Myofibroblastic Tumor: A Children’s Oncology Group Study Yaël P. Mossé, Stephan D. Voss, Megan S. Lim, Journal of Clinical Oncology	2017	396
ALK Mutations Confer Differential Oncogenic Activation and Sensitivity to ALK Inhibition Therapy in Neuroblastoma Scott C. Bresler, Daniel A. Weiser, Peter J. Huwe, Cancer Cell MedicineReceptor Tyrosine KinasePathologyCancer GeneticsOncology	2014	383
Copy number variation at 1q21.1 associated with neuroblastoma Sharon J. Diskin, Cuiping Hou, Joseph Glessner, Nature Neuro-oncologyTumor HeterogeneityMedicinePathologyCopy Number Variation	2009	358
Chromosome 6p22 Locus Associated with Clinically Aggressive Neuroblastoma John M. Maris, Yaël P. Mossé, Jonathan P. Bradfield, New England Journal of Medicine	2008	320
A Functional Screen Identifies miR-34a as a Candidate Neuroblastoma Tumor Suppressor Gene Kristina A. Cole, Edward F. Attiyeh, Yaël P. Mossé, Molecular Cancer Research Tumor BiologyDevelopmental BiologyHuman NeuroblastomaGliomaMedicine	2008	316
Integrative genomics identifies LMO1 as a neuroblastoma oncogene Kai Wang, Sharon J. Diskin, Haitao Zhang, Nature Neuroblastoma OncogeneCancer GenomicsCancer GeneticsMedicineCell Biology	2010	312

Page 1